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Impaired PI3K/Akt Activation-Mediated NF-jB
Inactivation Under Elevated TNF-a Is More
Vulnerable to Apoptosis in Vitiliginous Keratinocytes
Nan-Hyung Kim1,2, Songhee Jeon1,2, Hyun-Joo Lee1 and Ai-Young Lee1
Levels of the cytokines IL-6, IL-1a, and tumor necrosis factor-a (TNF-a) are significantly higher in lesional than in
non-lesional skin of patients with vitiligo. However, how cytokines affect pigmentation is not fully understood.
To examine the mechanism, Western blot analysis with TNF-a, Fas ligand (FasL), and downstream signaling
molecules such as I-kB, NF-kB, TNF-R1-associated factor 2, Akt, and PTEN (phosphatase and tension homologue)
were performed for the suction-blistered depigmented and normally pigmented epidermis from 10 patients.
Levels of TNF-a and FasL were significantly higher in the depigmented epidermis. Interestingly, phosphorylation
levels of I-kB, NF-kB, and Akt were lower in the depigmented epidermis. Moreover, PTEN, which could inhibit
the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway, was significantly higher in
depigmented epidermis, implying that vitiliginous keratinocytes may be more susceptible to TNF-a-mediated
apoptosis through impaired Akt and NF-kB activation. To test this hypothesis, cultured normal human
keratinocytes were treated with TNF-a in the presence of a PI3K inhibitor to suppress Akt activation.
Keratinocytes showing impaired Akt activation demonstrated increased apoptosis with less activation of NF-kB.
Thus, reduced activation of NF-kB via impaired PI3K/Akt activation under increased TNF-a levels could result in
increased apoptosis of vitiliginous keratinocytes.
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INTRODUCTION
Depigmentation in patients with vitiligo is caused by
melanocyte destruction. Although there are different hypoth-
eses and the exact mechanism is unclear, the melanocytes
involved in vitiligo may have inherent aberrations that make
them vulnerable to extracellular insults. The mechanism
underlying the elimination of melanocytes in vitiligo has
been considered apoptosis based on histological and some
laboratory data (Huang et al., 2002). Apoptosis is triggered by
Fas/tumor necrosis factor (TNF) receptors in activation-
induced cell death or by the loss of survival stimuli in passive
cell death. Epidermal melanocytes form functional and
structural units with keratinocytes, and structural abnormal-
ities in the keratinocytes (Moellmann et al., 1982; Bhawan
and Bhutani, 1983) have been related to functional changes
in patients with vitiligo (Maresca et al., 1997). We have
shown, using terminal deoxynucleotidyl TUNEL, that
significantly more keratinocytes show apoptosis in the
depigmented epidermis than in normally pigmented suc-
tion-blistered epidermis (Lee et al., 2004). This may result in
reduction of keratinocyte-derived melanocyte survival and
growth factors, in turn causing apoptosis of the melanocytes
(Lee et al., 2005). TUNEL-positive cells were also more frequent
in certain skin biopsies from patients with vitiligo (data not
shown), although no definite apoptotic cells were observed in
hematoxylin and eosin stained biopsied specimens.
There is growing evidence that cytokines are important in
the depigmentation process of vitiligo (Gordon et al., 1989;
Moretti et al., 2002). In vitiligo-affected skin, there are
significantly lower levels of granulocyte macrophage colony-
stimulating factor, basic fibroblast growth factor, and stem
cell factor as the mitogens for melanocytes. By contrast, there
are significantly higher levels of TNF-a, IL-1a, and IL-6 as
potent inhibitors of melanocyte growth than in perilesional,
non-lesional, and healthy skin (Moretti et al., 2002; Birol
et al., 2006). The increased TNF-a and Fas ligand (FasL) levels
may affect apoptosis among nearby keratinocytes as well as
the melanocytes in vitiligo lesions.
TNF-a is the key initiator of inflammation, and acts
through TNF-a receptors 1 and 2 (TNF-R1 and TNF-R2).
TNF-R1 recruits TNF-R1-associated death domain protein
(Tartaglia et al., 1993), which couples two receptors,
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resulting in opposing signal transduction. Interaction with
Fas-associating protein recruits caspase-8 and mediates
activation of the caspase cascade, whereas binding to the
TNF-R1-associated factor 2 (TRAF2) activates NF-kB (Hsu
et al., 1996; Wallach et al., 1998) through sequential
activation of I-kB kinases (IKKs) and I-kB.
Besides the NF-kB-inducing kinases, apoptosis signal-
regulating kinase (Akt), a serine/threonine kinase, is necessary
for TNF-a activation of NF-kB via IKK-a phosphorylation
(Ozes et al., 1999). Its role in NF-kB signaling may be an
essential antiapoptotic event. However, the mechanism
responsible for the activation of NF-kB by Akt remains
uncertain and may depend on the cell type analyzed (Kane
et al., 1999; Gustin et al., 2001).
Phosphatase and tensin homologue deleted from chromo-
some 10 (PTEN), which inhibits phosphatidylinositol 3-kinase
(PI3K) function, impairs TNF activation by Akt, resulting in
suppression of IKK and NF-kB activation (Gustin et al., 2001).
The phosphorylation of I-kB allows NF-kB to translocate to
the nucleus and to induce the expression of a number of
target genes that protect the cell from cell death (May and
Ghosh, 1998).
Here, we examined whether FasL as well as TNF-a affects
the apoptosis of vitiliginous keratinocytes, comparing their
downstream signaling molecules between suction-blistered
depigmented and normally pigmented epidermis. Although
TNF-a was increased in vitiligo lesions, the phosphorylation
levels of IKK, I-kB, NF-kB, and Akt were decreased, whereas
the level of PTEN was increased. Moreover, the inhibition of
PI3K/Akt-mediated NF-kB activation in TNF-a-treated cul-
tured keratinocytes resulted in apoptosis. These data suggest
that increased PTEN activity leading to impaired PI3K/Akt
activation and NF-kB dysfunction may promote TNF-a-
dependent apoptosis in keratinocytes from vitiligo lesion.
RESULTS
Levels of TNF-a and FasL
The level of TNF-a was much higher in the depigmented
epidermis than in the normally pigmented epidermis (Figure
1a) in all 10 specimens (P¼0.005; Figure 1b). To verify
whether keratinocytes produce TNF-a and the localization of
TNF-a-positive cells, an immunohistochemical staining ana-
lysis of TNF-a was carried out in depigmented epidermis
specimens. The TNF-a-positive cells were usually double-
stained with keratin 10 (data not shown), indicating that the
cells expressing TNF-a were indeed keratinocytes. The
intensity of staining in the depigmented epidermis (Figure
2e–h) was remarkably stronger compared with the normally
pigmented (Figure 2a–d). Strongly TNF-a-positive cells were
mainly found in the lower layer as a mosaic pattern (Figure
2g), as with the TUNEL-positive cells shown previously (Lee
et al., 2004, 2005).
FasL was clearly observed in both depigmented and
normally pigmented epidermis (Figure 3a). However, the
levels were significantly higher in the depigmented epidermis
(P¼0.022; Figure 3b). Immunohistochemical staining for
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Figure 1. TNF-a levels in depigmented and normally pigmented epidermis.
(a) Remarkably higher levels of TNF-a were detected in the depigmented
(L) than in the normally pigmented (N) suction-blistered epidermis. (b) The
expression levels were significantly higher in the depigmented than in the
normally pigmented epidermis (P¼ 0.005).
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Figure 2. Immunofluorescence staining with anti-TNF-a antibody. (a and e) Unstained samples; (b and f) staining of nuclei with Hoechst 33258 (blue);
(c and g) staining with anti-TNF-a antibody (green); and (d and h) staining with anti-TNF-a antibody (green) and counterstaining of nuclei with Hoechst 33258
(blue). (a–d) Cells were weakly stained with anti-TNF-a antibody in the normally pigmented suction-blistered epidermal specimens. (e–h) Remarkably more
cells were stained with anti-TNF-a antibody in the depigmented epidermal specimens than in the normally pigmented specimens. Bar¼200 mm.
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FasL protein was remarkably stronger in the depigmented
epidermis (Figure 4e–h) than in the normally pigmented
epidermis (Figure 4a–d).
Besides FasL, TNF-R1-associated death domain protein
couples the TRAF2 receptor, which activates NF-kB, and the
outcome from higher TNF-a expression depends on which
pathway is triggered (Hsu et al., 1996; Wallach et al., 1998).
However, the levels of TRAF2 were not significantly different
between the depigmented and normally pigmented epidermis
(data not shown).
Phosphorylation levels of NF-jB, I-jB, and IKK
As the downstream signaling molecules of TNF-a and FasL,
the phosphorylation of I-kB was decreased significantly
(P¼0.013) in the depigmented epidermal specimens (Figure
5a) compared with the controls (Figure 5b). The phosphory-
lation of NF-kB was parallel with that of I-kB (Figure 5c),
showing a significant decrease in the depigmented epidermis
(P¼0.028). The phosphorylation of IKK was also decreased
in the depigmented epidermis; however, this was tested in
only five samples (data not shown). These results indicate that
NF-kB activation may be impaired in depigmented epidermis
even though the levels of TNF-a are increased.
PTEN and Akt activation
The level of Akt phosphorylation was examined to account
for the impaired NF-kB activation. Akt phosphorylation was
significantly decreased (P¼0.021) in depigmented epidermis
(Figure 6a and b), whereas the expression levels of PTEN
were significantly higher (P¼0.017) in the depigmented than
in the normally pigmented epidermis (Figure 6c and d). Thus,
impaired NF-kB activation by TNF-a might be caused by
inactivation of Akt through increased PTEN levels in
depigmented epidermis.
Effects of the PI3K inhibitor, Wortmannin, on TNF-a-treated
cultured keratinocytes
Treatment with TNF-a increased the phosphorylation levels of
Akt and NF-kB in cultured normal human keratinocytes
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Figure 3. FasL immunostaining. (a) More FasL staining was observed in
the depigmented epidermis than in the normally pigmented epidermis.
(b) Levels of FasL were significantly higher in the depigmented than in the
normally pigmented epidermis (P¼ 0.022).
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Figure 5. Phosphorylation of I-jB and NF-jB. (a) Less I-kB was
phosphorylated in the depigmented than normally pigmented epidermis.
(b) The levels of I-kB phosphorylation were significantly lower in the
depigmented epidermis (P¼ 0.013). (c and d) Similar to p-I-kB,
phosphorylation of NF-kB decreased significantly in the depigmented
epidermis (P¼ 0.028).
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Figure 4. Immunofluorescence staining with FasL antibody. (a and e) Samples without staining; (b and f) staining of nuclei with Hoechst 33258 (blue);
(c and g) staining with anti-FasL antibody (green); and (d and h) staining with anti-FasL antibody (green) and counterstaining of nuclei with Hoechst 33258
(blue). (a–d) In the normally pigmented suction-blistered epidermal specimens, some cells stained evenly and weakly with the anti-FasL antibody.
(e–h) In the suction-blistered depigmented epidermal specimens, cells showed strong positivity to the anti-FasL antibody, particularly in the basal layer. Bar¼ 200mm.
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(Figure 7a). However, inhibition of Akt phosphorylation with
Wortmannin, a PI3K inhibitor, resulted in a marked decrease
in NF-kB phosphorylation (Figure 7a). The meaning of this
was clarified by the TUNEL assay, where significantly more
(P¼0.043) apoptotic keratinocytes were detected in treated
than in untreated cells (Figure 7b).
DISCUSSION
Vitiligo is a skin disease caused by selective destruction of
melanocytes, and is characterized by depigmented spots.
Melanocytes and keratinocytes seem to exhibit a functional
and structural close relationship, mediated at least in part by
keratinocyte-derived cytokines, which seem important for the
survival and activity of melanocytes and keratinocytes.
In this study, we found higher levels of TNF-a and FasL,
consistent with results from cytokine studies in subjects with
vitiligo (Moretti et al., 2002; Birol et al., 2006). Although how
cytokines affect pigmentation is not fully understood, we
found lower levels of phosphorylation of IKK, I-kB-a, and NF-
kB in depigmented epidermis, whereas there was higher
phosphorylation of NF-kB with apoptosis of only a few
keratinocytes in cultured normal human keratinocytes treated
with TNF-a. As there are more apoptotic keratinocytes in
depigmented than in normally pigmented epidermis of
individuals with vitiligo (Lee et al., 2004), it is likely that
impaired NF-kB activation under increased TNF-a levels may
contribute to apoptosis.
Our results also demonstrated impaired Akt activation in
vitiligo lesions, although TNF-a activates PI3K and its
downstream target, Akt, by binding to TNF-R1 (Ozes et al.,
1999). TNF-R1 bound to TNF-a recruits TNF-R1-associated
death domain protein (Tartaglia et al., 1993). TRAF2, which is
one of the TNF-R1-associated death domain protein recep-
tors, activates NF-kB (Hsu et al., 1996; Wallach et al., 1998).
The similar patterns between TNF-a and FasL levels indicate
that TNF-R1-mediated processes continued, although no
significant difference was found in TRAF2 expression
between the pairs of epidermal specimens. Here, the
important consideration was what induced the impairment
of PI3K/Akt signaling. Activated PI3K promotes the formation
of the lipid second messenger phosphatidylinositol 3-
phosphate, which plays an essential role in the activation of
Akt (Ruderman et al., 1990; Stokoe et al., 1997). The PTEN
tumor suppressor is a doubly specific phosphatase that
impairs survival signaling emanating from PI3K by depho-
sphorylating and inactivating phosphatidylinositol 3-phos-
phate (Myers et al., 1998; Stambolic et al., 1998). Increased
PTEN with impaired Akt activation indicates that PTEN plays
a role in defected PI3K/Akt signaling, rendering the vitiligi-
nous keratinocytes susceptible to TNF-a-mediated toxicity
through inactivation of NF-kB. Besides, PTEN directly inhibits
activation of NF-kB by TNF-a in 293 cells (Gustin et al.,
2001).
*P=0.021 *P=0.017
N N
b
a c
d
L L
N L N L
Np-Akt
Akt
L N L
*
*
R
at
io
s 
of
 in
cr
em
en
t 
(L
/N
)
R
at
io
s 
of
 in
cr
em
en
t 
(L
/N
)
0 0
0.8
0.8
0.6
0.60.4
0.40.2
0.2
1.2
Fold Fold
1.2
1.4
1.6
1.8
2
1
1
PTEN
Figure 6. Phosphorylation of Akt and immunostaining for PTEN.
(a) Phosphorylation of Akt decreased in the depigmented epidermis.
(b) The phosphorylated levels of Akt were significantly lower in the
depigmented epidermis (P¼ 0.021). (c) Higher levels of PTEN were detected
in the depigmented than in the normally pigmented epidermis. (d) The levels
were significantly different between the paired epidermal specimens (P¼ 0.017).
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Figure 7. Western blot analysis and TUNEL assay in TNF-a-treated cultured
keratinocytes in the absence or presence of the PI3K inhibitor. (a) The
phosphorylation levels of NF-kB and Akt were examined at 1 and 4 hours after
treatment with TNF-a with or without Wortmannin and compared with
untreated controls. (b) In the absence of Wortmannin, only a few cells were
TUNEL positive with the TNF-a treatment. However, the TUNEL-positive cells
were remarkably increased (P¼ 0.043) whenever Akt phosphorylation was
inhibited. (c) The phosphorylation of Akt and NF-kB clearly increased with
the TNF-a treatment. However, NF-kB phosphorylation was markedly
inhibited in the presence of the PI3K inhibitor, which abolished Akt
phosphorylation. W: Wortmanin.
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In summary, we demonstrated significantly higher levels of
FasL, as well as of TNF-a, a potent inhibitor of keratinocyte
growth in depigmented epidermis. These could inhibit
melanocyte growth at least by reduction of keratinocyte-
derived melanocyte growth factors including stem cell factor.
The cytokines appear to induce apoptosis in vitiliginous
epidermis via impaired phosphorylation of I-kB, NF-kB, IKK,
and Akt, and increased PTEN expression in depigmented
epidermis. This postulated mechanism was supported by an
in vitro study that PI3K/Akt signaling-defected keratinocytes
are more vulnerable to apoptosis by TNF-a treatment. Thus,
the Akt activator may be a novel therapeutic target for
subjects with vitiligo by reducing the apoptosis of keratino-
cytes under increased TNF-a levels.
MATERIALS AND METHODS
Specimens of patients
Ten patients diagnosed with vitiligo (five men and five women) aged
between 11 and 54 years (mean 28 years) were included in the
study. Four had segmental, five had generalized, and one had
localized vitiligo. The Institutional Review Board of Dongguk
University International Hospital approved this study, and the study
was conducted according to the Declaration of Helsinki Principles.
After obtaining informed written consent, epidermal specimens were
taken from each patient using suction blistering. Pairs of normally
pigmented and depigmented epidermis samples were taken for
direct comparisons. All patients had a stable lesion at the time of
sampling. The location of the depigmented lesions varied, with two
of the segmental and one of the generalized and localized types
occurring in sun-exposed areas. Control skin was taken from the
lower abdomen. Negative pressure between 200 and 250 mm Hg
was applied to normally pigmented and depigmented skin to
generate suction blisters. The roofs of the suction blisters were used
for Western blotting and immunohistochemistry.
Normal human epidermal keratinocyte culture
Skin specimens obtained from repeated cesarean sections and
circumcisions were used for cultures. Epidermis was separated from
dermis after treatment with 2.4 U/ml of dispase (no. 295 825; Roche,
Mannheim, Germany) for 1 hour. The epidermal sheets were treated
with 0.05% trypsin for 10 minutes to produce a suspension of
individual epidermal cells. The cells were suspended in EpiLife
Medium (no. M-EPI-500-CA; Cascade Biologics, Portland, OR)
supplemented with bovine pituitary extract, bovine insulin, hydro-
cortisone, human epidermal growth factor and bovine transferrin
(no. S-001-5; Cascade Biologics). When the cells reached con-
fluence, they were detached from the flask and seeded into new
culture flasks.
Keratinocytes from passage numbers three or four were used for
the experiments. EpiLife Medium with supplements was changed to
medium without supplement for 24 hours before treatment with
TNF-a or FasL. The cells were treated with 100 ng/ml of human
recombinant TNF-a (G524a; Promega, Madison, WI) or 200 ng/ml of
FasL (ab2441; Abcam, Cambridge, UK) for 1, 4, 24, and 48 hours.
Five cell lines were examined.
For the inhibition experiments, keratinocytes were incubated in
EpiLife Medium containing 100 nM of the PI3K inhibitor Wortmannin
(Calbiochem, La Jolla, CA) for 60 minutes before TNF-a treatment.
Western blot analysis
Western blot analysis was performed as described (Lee et al., 2004).
Briefly, depigmented and normally pigmented epidermis samples
and cultured cells were homogenized in ice-cold homogenization
buffer containing 50 mM Tris-base (pH 7.5), 150 mM NaCl, 2 mM
EDTA, 1% glycerol, 10 mM NaF, 10 mM Na pyrophosphate, and
protease inhibitors (0.1 mM phenylmethylsulfonylfluoride, 5mg/ml
aprotinin, and 5mg/ml leupeptin). Equal amounts of the extracted
protein (30 mg) were resolved using 8–12.5% SDS-PAGE and
transferred to nitrocellulose membranes. After being blocked using
5% non-fat dry milk in Tris-buffered saline (pH 7.6), the membranes
were incubated with antibodies to human TNF-a (rabbit polyclonal;
Santa Cruz Biotechnology Inc., Santa Cruz, CA), FasL (rabbit
polyclonal; Santa Cruz Biotechnology Inc.), TRAF2 (rabbit poly-
clonal; Santa Cruz Biotechnology Inc.), phospho-I-kB-a, I-kB-a,
phosphor-NF-kB, NF-kB, phospho-Akt, Akt, and PTEN (rabbit
polyclonal; Cell Signaling Technology, Beverly, MA), diluted
1:1,000 in blocking solution overnight at 41C. The membranes were
further incubated with an anti-rabbit or anti-mouse horseradish
peroxidase-conjugated antibody (Jackson Laboratories, West Grove,
PA). The membranes were treated with an enhanced chemilumine-
scence solution (ECL kit; Amersham Life Sciences, Buckinghamshire,
UK), and the signals were captured on an Image Reader (LAS-3,000;
Fuji Photo Film, Tokyo, Japan).
To monitor the amount of protein loaded into each lane, the
membranes were treated with a stripping buffer and reprobed with
an mAb against b-actin (Sigma-Aldrich, St Louis, MO). The protein
bands were analyzed by densitometry.
Immunohistochemistry
For immunofluorescence staining of TNF-a and FasL, fixed
depigmented and normally pigmented epidermis samples were
embedded in paraffin wax and sectioned at 5 mm. After deparaffini-
zation and rehydration, the sections were boiled in a 100 mM citrate
solution (pH 6.0) for 1 minute on a hotplate. The sections were
preincubated with 3% bovine serum albumin for 1 hour at room
temperature, and then reacted sequentially with 1:100 anti-TNF-a or
anti-FasL antibodies for 1 hour at room temperature and Alexa Fluor-
labeled goat anti-rabbit IgG (488; Molecular Probes, Eugene, OR) for
1 hour at room temperature. The sections were double stained with
anti-K10 antibody (mouse monoclonal; Santa Cruz Biotechnology
Inc.) and Alexa Fluor-labeled goat anti-mouse IgG (594; Molecular
Probes). The nuclei were counterstained with Hoechst 33258
(Sigma-Aldrich). The stained specimens were observed using an
image analysis system (Dp Manager 2.1; Olympus Optical Co.,
Tokyo, Japan).
Apoptosis
Apoptosis in TNF-a-treated cultured keratinocytes was evaluated
using a TUNEL kit (in situ cell death detection kit; Roche). The cells,
either in the absence or presence of Wortmannin, were fixed in 4%
paraformaldehyde and incubated in the TUNEL reaction mixture
included in the kit for 1 hour at 371C. After washing with distilled
water, the nuclei were counterstained with Hoechst 33258 (Sigma-
Aldrich) and then observed under a fluorescence microscope. For a
quantitative analysis of apoptosis, four random fields were photo-
graphed and apoptotic and total cells were counted. Apoptotic cells
were expressed as the number per 1,000 total cell population.
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Statistical analysis
The Wilcoxon signed-rank test for correlated samples was used to
compare differences between the depigmented and the normally
pigmented samples. Po0.05 was considered statistically significant.
All results are presented as the mean7SD of the combined data from
replicate experiments.
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